Synthetic lethality in cancer: a protocol for scoping review of gene interactions from synthetic lethal screens and functional studies
Abstract Background Two genes are synthetically lethal if loss of function of either one of the two genes does not result in cell death, whereas loss of function of both genes together results in being detrimental to cell survival. This concept has been the basis for developing personalized, precisi...
Saved in:
| Main Authors: | Raashi Chauhan, Rama Rao Damerla, Vijay Shree Dhyani |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | Systematic Reviews |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13643-025-02814-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CRISPR/Cas9 Technology Providing the Therapeutic Landscape of Metastatic Prostate Cancer
by: Jieun Park, et al.
Published: (2024-11-01) -
MYC and the unfolded protein response in cancer: synthetic lethal partners in crime?
by: Tingting Zhang, et al.
Published: (2020-04-01) -
Application and research progress of synthetic lethality in the development of anticancer therapeutic drugs
by: Xiaoliang Gong, et al.
Published: (2024-11-01) -
Genome‐scale gene/reaction essentiality and synthetic lethality analysis
by: Patrick F Suthers, et al.
Published: (2009-08-01) -
An interpretable artificial intelligence framework for designing synthetic lethality-based anti-cancer combination therapies
by: Jing Wang, et al.
Published: (2024-11-01)